Lista de obras - Sastre-Garriga J - Dominio Público Uruguay

'Brain reserve' and 'cognitive reserve' should always be taken into account when studying neurodegeneration - NO.

artículo científico publicado en 2018

A functional magnetic resonance proof of concept pilot trial of cognitive rehabilitation in multiple sclerosis.

artículo científico publicado en 2010

A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis.

artículo científico publicado en 2009

A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis

artículo científico publicado en 2009

Abnormalities in normal appearing tissues in early primary progressive multiple sclerosis and their relation to disability: a tissue specific magnetisation transfer study

artículo científico publicado en 2006

Adding brain volume measures into response criteria in multiple sclerosis: the Río-4 score

artículo científico publicado en 2020

Adherence in multiple sclerosis (ADAMS): classification, relevance, and research needs. A meeting report.

artículo científico publicado en 2014

An uncommon first manifestation of multiple sclerosis: Tako-Tsubo cardiomyopathy.

artículo científico publicado en 2016

Anticardiolipin antibodies are not a useful screening tool in a nonselected large group of patients with multiple sclerosis

artículo científico publicado en 2001

Assess, compare and enhance the status of Persons with Multiple Sclerosis (MS) in Europe: a European Register for MS.

artículo científico

Baseline MRI predicts future attacks and disability in clinically isolated syndromes.

artículo científico publicado en 2006

Brain Atrophy in Multiple Sclerosis: Clinical Relevance and Technical Aspects.

artículo científico publicado en 2017

Brain Volume Loss During the First Year of Interferon-Beta Treatment in Multiple Sclerosis: Baseline Inflammation and Regional Brain Volume Dynamics

artículo científico publicado en 2016

Brain atrophy 15 years after CIS: Baseline and follow-up clinico-radiological correlations.

artículo científico publicado en 2017

Brain atrophy and lesion load predict long term disability in multiple sclerosis

artículo científico publicado en 2013

Brain atrophy in natalizumab-treated patients: A 3-year follow-up

artículo científico publicado en 2014

COVID-19 in MS patients: susceptibility, severity risk factors and serological response

scientific article published on 19 December 2020

Cervical Cord Atrophy and Long-Term Disease Progression in Patients with Primary-Progressive Multiple Sclerosis.

artículo científico publicado en 2017

Change in the clinical activity of multiple sclerosis after treatment switch for suboptimal response

article

Classic Block Design "Pseudo"-Resting-State fMRI Changes After a Neurorehabilitation Program in Patients with Multiple Sclerosis

artículo científico publicado en 2018

Clinical impact of early brain atrophy in clinically isolated syndromes

artículo científico publicado en 2013

Clinical impact of intravenous methylprednisolone in attacks of multiple sclerosis.

artículo científico publicado en 2004

Clinical monitoring of multiple sclerosis should routinely include spinal cord imaging - Commentary

scientific article published on 23 July 2018

Clinical, paraclinical and serological findings in Susac syndrome: an international multicenter study

artículo científico publicado en 2014

Clinically definite multiple sclerosis after radiological Schilder-like onset

scientific article published on 01 July 2003

Comparison between gadolinium-enhanced 2D T1-weighted gradient-echo and spin-echo sequences in the detection of active multiple sclerosis lesions on 3.0T MRI.

artículo científico publicado en 2016

Contribution of the symptomatic lesion in establishing MS diagnosis and prognosis

artículo científico publicado en 2016

Conversion to multiple sclerosis after a clinically isolated syndrome of the brainstem: cranial magnetic resonance imaging, cerebrospinal fluid and neurophysiological findings.

artículo científico publicado en 2003

Cord atrophy separates early primary progressive and relapsing remitting multiple sclerosis

artículo científico publicado en 2006

Cumulative Dose of Macrocyclic Gadolinium-Based Contrast Agent Improves Detection of Enhancing Lesions in Patients with Multiple Sclerosis.

artículo científico publicado en 2017

Decreased MMP-9 production in primary progressive multiple sclerosis patients

article

Deep grey matter volume loss drives disability worsening in multiple sclerosis.

artículo científico publicado en 2018

Defining high, medium and low impact prognostic factors for developing multiple sclerosis

artículo científico publicado en 2015

Diagnosis and trials of clinically isolated syndrome

scientific article published on 02 September 2014

Diagnosis of multiple sclerosis: a multicentre study to compare revised McDonald-2010 and Filippi-2010 criteria

artículo científico publicado en 2017

Dimethyl fumarate is coming of age

artículo científico publicado en 2016

Disability progression markers over 6-12 years in interferon-β-treated multiple sclerosis patients.

artículo científico publicado en 2017

Distinct influence of different vascular risk factors on white matter brain lesions in multiple sclerosis

artículo científico publicado en 2020

Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?

artículo científico

Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changes.

artículo científico publicado en 2013

Editorial

Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates

artículo científico publicado en 2017

Evaluating the response to glatiramer acetate in relapsing–remitting multiple sclerosis (RRMS) patients

article

Grey and white matter atrophy in early clinical stages of primary progressive multiple sclerosis

artículo científico publicado en 2004

Grey matter atrophy is associated with disability increase in natalizumab-treated patients.

artículo científico publicado en 2016

Highlights from the 31st ECTRIMS congress - Barcelona 2015

artículo científico publicado en 2016

Increase in the prevalence of multiple sclerosis over a 17-year period in Osona, Catalonia, Spain

artículo científico publicado en 2012

Interferon β-1b for the treatment of primary progressive multiple sclerosis: five-year clinical trial follow-up.

artículo científico publicado en 2011

Is inflammation important in early PPMS? a longitudinal MRI study.

artículo científico publicado en 2005

Juxtacortical Lesions and Cortical Thinning in Multiple Sclerosis.

artículo científico publicado en 2015

Keeping standards of multiple sclerosis care through the COVID-19 pandemic

scientific article published on 19 June 2020

Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis

scientific article published on 21 January 2008

Leptomeningeal enhancement in Susac's syndrome and multiple sclerosis: Time to expect the unexpected?

artículo científico publicado en 2016

Lesion filling effect in regional brain volume estimations: a study in multiple sclerosis patients with low lesion load.

artículo científico publicado en 2016

Lesion location may predict disability in multiple sclerosis

artículo científico publicado en 2010

Lesion topographies in multiple sclerosis diagnosis: A reappraisal

artículo científico publicado en 2017

Localized grey matter atrophy in multiple sclerosis: a meta-analysis of voxel-based morphometry studies and associations with functional disability.

artículo científico

Longitudinal assessment of multiple sclerosis with the brain-age paradigm

scientific article published on 14 April 2020

Longitudinal fMRI studies: Exploring brain plasticity and repair in MS.

artículo científico publicado en 2015

Lower motor neuron disease in a HIV-2 infected woman

article

MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice

artículo científico publicado en 2020

MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines

artículo científico publicado en 2016

Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease duration

artículo científico publicado en 2013

Magnetisation transfer ratio in the normal appearing white matter predicts progression of disability over 1 year in early primary progressive multiple sclerosis.

artículo científico publicado en 2007

Measurement of Cortical Thickness and Volume of Subcortical Structures in Multiple Sclerosis: Agreement between 2D Spin-Echo and 3D MPRAGE T1-Weighted Images

artículo científico publicado en 2016

Measurement of Whole-Brain and Gray Matter Atrophy in Multiple Sclerosis: Assessment with MR Imaging.

artículo científico publicado en 2018

Measures in the first year of therapy predict the response to interferon β in MS

article

Metabolite changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosis.

artículo científico publicado en 2005

Multiple sclerosis management during the COVID-19 pandemic

artículo científico publicado en 2020

Multiple sclerosis registries in Europe - An updated mapping survey

artículo científico publicado en 2018

Multiple sclerosis registries in Europe – results of a systematic survey

artículo científico publicado en 2014

Myasthenia gravis following alemtuzumab therapy for multiple sclerosis

scientific article published on 24 August 2018

Myelopathy in seronegative Sjögren syndrome and/or primary progressive multiple sclerosis

artículo científico publicado en 2003

Natalizumab discontinuation after PML risk stratification: outcome from a shared and informed decision

artículo científico publicado en 2012

Neurofilament light chain level is a weak risk factor for the development of MS.

artículo científico publicado en 2016

New areas, new challenges...

artículo científico publicado en 2017

New treatment measurements for treatment effects on relapses and progression.

artículo científico publicado en 2008

One step forward in the quest for evidence of the efficacy of cognitive rehabilitation in multiple sclerosis.

artículo científico publicado en 2014

Onset-adjusted incidence of multiple sclerosis in the Girona province (Spain): Evidence of increasing risk in the south of Europe.

artículo científico publicado en 2015

Patient and caregiver involvement in the formulation of guideline questions: findings from the European Academy of Neurology guideline on palliative care of people with severe multiple sclerosis

scientific article published on 09 September 2018

Performance of five research-domain automated WM lesion segmentation methods in a multi-center MS study.

artículo científico publicado en 2017

Plasma cerebrosterol and magnetic resonance imaging measures in multiple sclerosis.

artículo científico publicado en 2005

Plasma levels of 15d-PGJ2are not altered in multiple sclerosis

artículo científico publicado en 2009

Polyglandular autoimmune syndrome type II and multiple sclerosis

artículo científico publicado en 2001

Precision medicine in multiple sclerosis: biomarkers for diagnosis, prognosis, and treatment response.

artículo científico publicado en 2016

Predicting progression in primary progressive multiple sclerosis: A 10-year multicenter study

scientific article published on 01 June 2008

Predictive markers of disease evolution after a CIS in everyday practice.

artículo científico publicado en 2014

Predictive value of early brain atrophy on response in patients treated with interferon β

artículo científico publicado en 2015

Preliminary validation study of the Spanish version of the satisfaction with life scale in persons with multiple sclerosis.

artículo científico publicado en 2013

Primary progressive multiple sclerosis diagnostic criteria: a reappraisal.

artículo científico publicado en 2009

Progression of regional grey matter atrophy in multiple sclerosis.

artículo científico publicado en 2018

Quantifying brain tissue volume in multiple sclerosis with automated lesion segmentation and filling.

artículo científico publicado en 2015

Ratio of T1-Weighted to T2-Weighted Signal Intensity as a Measure of Tissue Integrity: Comparison with Magnetization Transfer Ratio in Patients with Multiple Sclerosis

scientific article published on 05 March 2020

Regional gray matter atrophy in early primary progressive multiple sclerosis: a voxel-based morphometry study.

artículo científico publicado en 2006

Remodelling of the Scientific Committee and a new series of neuroepidemiology reviews

artículo científico publicado en 2018

Response to botulinum toxin in a case of rigid spine syndrome.

artículo científico publicado en 2001

Risk acceptance in multiple sclerosis patients on natalizumab treatment.

artículo científico publicado en 2013

Risk knowledge of people with relapsing-remitting multiple sclerosis - Results of an international survey

artículo científico publicado en 2018

Rituximab: its efficacy, effectiveness and safety in the treatment of multiple sclerosis

artículo científico publicado en 2018

Role of MRI criteria and OB for diagnosing multiple sclerosis in patients presenting with clinically isolated syndromes.

artículo científico publicado en 2009

Severe hypertriglyceridemia associated with teriflunomide in a patient with multiple sclerosis: A case report.

artículo científico publicado en 2018

Should we systematically test patients with clinically isolated syndrome for auto-antibodies?

artículo científico publicado en 2015

Significant clinical worsening after natalizumab withdrawal: Predictive factors

article

Simultaneous CMV and Listeria infection following alemtuzumab treatment for multiple sclerosis

artículo científico publicado en 2018

Specificity of Barkhof Criteria in Predicting Conversion to Multiple Sclerosis When Applied to Clinically Isolated Brainstem Syndromes

artículo científico publicado en 2004

Spinal cord lesions: A modest contributor to diagnosis in clinically isolated syndromes but a relevant prognostic factor

artículo científico publicado en 2017

THC and CBD oromucosal spray (Sativex®) in the management of spasticity associated with multiple sclerosis.

artículo científico publicado en 2011

The ACROSS study: Long-term efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis

artículo científico publicado en 2020

The HLA locus and multiple sclerosis in Spain. Role in disease susceptibility, clinical course and response to interferon-β

article

The current role of MRI in differentiating multiple sclerosis from its imaging mimics

artículo científico publicado en 2018

The current role of MRI in differentiating multiple sclerosis from its imaging mimics.

artículo científico publicado en 2018

The role of pontine lesion location in differentiating multiple sclerosis from vascular risk factor-related small vessel disease

scientific article published on 06 August 2020

The role of the cerebellum in multiple sclerosis-150 years after Charcot.

artículo científico publicado en 2018

The value of oligoclonal bands in the multiple sclerosis diagnostic criteria.

artículo científico publicado en 2018

Transient Ischaemic Attack: A Common Initial Manifestation of Cardiac Myxomas

scientific article published on 01 January 2001

Treating relapsing-remitting multiple sclerosis: therapy effects on brain atrophy.

artículo científico publicado en 2015

Treatment of multiple sclerosis - success from bench to bedside

artículo científico publicado en 2019

Unraveling treatment response in multiple sclerosis: A clinical and MRI challenge

artículo científico publicado en 2018

Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI.

artículo científico publicado en 2018

Value of 3T Susceptibility-Weighted Imaging in the Diagnosis of Multiple Sclerosis

scientific article published on 21 May 2020

Value of NMO-IgG determination at the time of presentation as CIS

artículo científico publicado en 2012

Variations in chemokine receptor and cytokine expression during pregnancy in multiple sclerosis patients

artículo científico publicado en 2006

Very early scans for demonstrating dissemination in time in multiple sclerosis

artículo científico publicado en 2008

[Monoclonal antibodies in [corrected] development in [corrected] multiple sclerosis]

scientific article published on 08 April 2011

Lista de obras de Sastre-Garriga J

'Brain reserve' and 'cognitive reserve' should always be taken into account when studying neurodegeneration - NO.

A functional magnetic resonance proof of concept pilot trial of cognitive rehabilitation in multiple sclerosis.

A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis.

A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis

Abnormalities in normal appearing tissues in early primary progressive multiple sclerosis and their relation to disability: a tissue specific magnetisation transfer study

Adding brain volume measures into response criteria in multiple sclerosis: the Río-4 score

Adherence in multiple sclerosis (ADAMS): classification, relevance, and research needs. A meeting report.

An uncommon first manifestation of multiple sclerosis: Tako-Tsubo cardiomyopathy.

Anticardiolipin antibodies are not a useful screening tool in a nonselected large group of patients with multiple sclerosis

Assess, compare and enhance the status of Persons with Multiple Sclerosis (MS) in Europe: a European Register for MS.

Baseline MRI predicts future attacks and disability in clinically isolated syndromes.

Brain Atrophy in Multiple Sclerosis: Clinical Relevance and Technical Aspects.

Brain Volume Loss During the First Year of Interferon-Beta Treatment in Multiple Sclerosis: Baseline Inflammation and Regional Brain Volume Dynamics

Brain atrophy 15 years after CIS: Baseline and follow-up clinico-radiological correlations.

Brain atrophy and lesion load predict long term disability in multiple sclerosis

Brain atrophy in natalizumab-treated patients: A 3-year follow-up

COVID-19 in MS patients: susceptibility, severity risk factors and serological response

Cervical Cord Atrophy and Long-Term Disease Progression in Patients with Primary-Progressive Multiple Sclerosis.

Change in the clinical activity of multiple sclerosis after treatment switch for suboptimal response

Classic Block Design "Pseudo"-Resting-State fMRI Changes After a Neurorehabilitation Program in Patients with Multiple Sclerosis

Clinical impact of early brain atrophy in clinically isolated syndromes

Clinical impact of intravenous methylprednisolone in attacks of multiple sclerosis.

Clinical monitoring of multiple sclerosis should routinely include spinal cord imaging - Commentary

Clinical, paraclinical and serological findings in Susac syndrome: an international multicenter study

Clinically definite multiple sclerosis after radiological Schilder-like onset

Comparison between gadolinium-enhanced 2D T1-weighted gradient-echo and spin-echo sequences in the detection of active multiple sclerosis lesions on 3.0T MRI.

Contribution of the symptomatic lesion in establishing MS diagnosis and prognosis

Conversion to multiple sclerosis after a clinically isolated syndrome of the brainstem: cranial magnetic resonance imaging, cerebrospinal fluid and neurophysiological findings.

Cord atrophy separates early primary progressive and relapsing remitting multiple sclerosis

Cumulative Dose of Macrocyclic Gadolinium-Based Contrast Agent Improves Detection of Enhancing Lesions in Patients with Multiple Sclerosis.

Decreased MMP-9 production in primary progressive multiple sclerosis patients

Deep grey matter volume loss drives disability worsening in multiple sclerosis.

Defining high, medium and low impact prognostic factors for developing multiple sclerosis

Diagnosis and trials of clinically isolated syndrome

Diagnosis of multiple sclerosis: a multicentre study to compare revised McDonald-2010 and Filippi-2010 criteria

Dimethyl fumarate is coming of age

Disability progression markers over 6-12 years in interferon-β-treated multiple sclerosis patients.

Distinct influence of different vascular risk factors on white matter brain lesions in multiple sclerosis

Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?

Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changes.

Editorial

Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates

Evaluating the response to glatiramer acetate in relapsing–remitting multiple sclerosis (RRMS) patients

Grey and white matter atrophy in early clinical stages of primary progressive multiple sclerosis

Grey matter atrophy is associated with disability increase in natalizumab-treated patients.

Highlights from the 31st ECTRIMS congress - Barcelona 2015

Increase in the prevalence of multiple sclerosis over a 17-year period in Osona, Catalonia, Spain

Interferon β-1b for the treatment of primary progressive multiple sclerosis: five-year clinical trial follow-up.

Is inflammation important in early PPMS? a longitudinal MRI study.

Juxtacortical Lesions and Cortical Thinning in Multiple Sclerosis.

Keeping standards of multiple sclerosis care through the COVID-19 pandemic

Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis

Leptomeningeal enhancement in Susac's syndrome and multiple sclerosis: Time to expect the unexpected?

Lesion filling effect in regional brain volume estimations: a study in multiple sclerosis patients with low lesion load.

Lesion location may predict disability in multiple sclerosis

Lesion topographies in multiple sclerosis diagnosis: A reappraisal

Localized grey matter atrophy in multiple sclerosis: a meta-analysis of voxel-based morphometry studies and associations with functional disability.

Longitudinal assessment of multiple sclerosis with the brain-age paradigm

Longitudinal fMRI studies: Exploring brain plasticity and repair in MS.

Lower motor neuron disease in a HIV-2 infected woman

MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice

MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines

Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease duration

Magnetisation transfer ratio in the normal appearing white matter predicts progression of disability over 1 year in early primary progressive multiple sclerosis.

Measurement of Cortical Thickness and Volume of Subcortical Structures in Multiple Sclerosis: Agreement between 2D Spin-Echo and 3D MPRAGE T1-Weighted Images

Measurement of Whole-Brain and Gray Matter Atrophy in Multiple Sclerosis: Assessment with MR Imaging.

Measures in the first year of therapy predict the response to interferon β in MS

Metabolite changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosis.

Multiple sclerosis management during the COVID-19 pandemic

Multiple sclerosis registries in Europe - An updated mapping survey

Multiple sclerosis registries in Europe – results of a systematic survey

Myasthenia gravis following alemtuzumab therapy for multiple sclerosis

Myelopathy in seronegative Sjögren syndrome and/or primary progressive multiple sclerosis

Natalizumab discontinuation after PML risk stratification: outcome from a shared and informed decision

Neurofilament light chain level is a weak risk factor for the development of MS.

New areas, new challenges...

New treatment measurements for treatment effects on relapses and progression.

One step forward in the quest for evidence of the efficacy of cognitive rehabilitation in multiple sclerosis.

Onset-adjusted incidence of multiple sclerosis in the Girona province (Spain): Evidence of increasing risk in the south of Europe.